13D/13G Filings - Bicara Therapeutics Inc. (BCAX)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2025-03-03
09:14 am
Purchase
2025-02-2413GBicara Therapeutics Inc. Common Stock
BCAX
FMR LLC2,803,807
5.200%
686,719increase
(+32.44%)
Filing
History
2025-02-12
09:16 am
Sale
2024-12-3113GBicara Therapeutics Inc. Common Stock
BCAX
FMR LLC2,117,088
3.900%
-378,245decrease
(-15.16%)
Filing
History
2024-09-26
4:30 pm
Purchase
2024-09-1613GBicara Therapeutics Inc. Common Stock
BCAX
Invus Public Equities, L.P.3,072,827
5.700%
3,072,827increase
(New Position)
Filing
History
2024-09-26
4:16 pm
Purchase
2024-09-1613GBicara Therapeutics Inc. Common Stock
BCAX
Red Tree GP, LLC3,170,509
5.800%
3,170,509increase
(New Position)
Filing
History
2024-09-23
4:17 pm
Purchase
2024-09-1613DBicara Therapeutics Inc. Common Stock
BCAX
RA CAPITAL MANAGEMENT L.P.6,955,993
12.800%
6,955,993increase
(New Position)
Filing
History
2024-09-18
5:10 pm
Purchase
2024-09-1613DBicara Therapeutics Inc. Common Stock
BCAX
TPG GP A LLC3,010,425
5.500%
3,010,425increase
(New Position)
Filing
History
2024-09-18
11:57 am
Purchase
2024-09-1813GBicara Therapeutics Inc. Common Stock
BCAX
FMR LLC2,495,333
5.095%
2,495,333increase
(New Position)
Filing
History